Quantcast

Latest American Society of Clinical Oncology Stories

2014-05-23 08:24:25

Remedy's registry technology was recently selected as the new technology platform for the ASCO Quality Oncology Practice Initiative (QOPI) SALT LAKE CITY, May 23, 2014 /PRNewswire/ -- Remedy Informatics announced today that it will exhibit at the upcoming 50(th) anniversary American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Remedy will be available to answer questions about and demo some of its informatics solutions from Saturday, May 31 to Tuesday, June 3 at the...

2014-05-22 08:29:15

QUÉBEC CITY, May 22, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) (the "Company") today announced that a poster will be presented on the design of its current ZoptEC (Zoptarelin doxorubicin in Endometrial Cancer) Phase 3 trial in women with advanced, recurrent or metastatic endometrial cancer. The poster will be presented by lead investigator, David S. Miller MD, of the University of Texas Southwestern Medical Center in Dallas, during the 50(th) Annual Meeting...

2014-05-20 23:11:42

Visitors to Miraca Life Science’s tradeshow booth #8123 can learn about new technology partnerships and product offerings. Irving, Texas (PRWEB) May 20, 2014 Miraca Life Sciences, (MLS) the nation’s largest independent anatomic pathology lab, will announce new services for oncology practices at the 50th annual meeting of the American Society of Clinical Oncology (ASCO). Visitors to Miraca Life Science’s tradeshow booth #8123 can learn about new technology partnerships and product...

2014-05-15 08:31:40

Comprehensive Molecular Profiling Provides Oncologists Treating Patients with Rare, Aggressive or Refractory Cancers with Better Understanding of How to Treat Cancer IRVING, Texas, May 15, 2014 /PRNewswire/ -- Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of precision medicine, today announced the acceptance of 34 key clinical studies by the American Society of Clinical Oncology (ASCO) for their 50(th) annual meeting to be held May 30 through June 3 in...

2014-05-14 16:29:17

DecisionDx-Melanoma identifies patients with negative sentinel lymph node biopsies who are at high risk of metastasis FRIENDSWOOD, Texas, May 14, 2014 /PRNewswire/ -- Castle Biosciences Inc. announced today that abstracts reporting additional clinical validation data for two of its molecular tests -- one focused on melanoma and the other on esophageal adenocarcinoma -- will be presented at the 50(th) Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 30-June 3,...

2014-05-14 08:30:37

BOULDER, Colo., May 14, 2014 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today announced presentations on its MEK inhibitors, binimetinib (MEK162) (co-developing with Novartis) and selumetinib (licensed to AstraZeneca) at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 30 - June 3, 2014 in Chicago, Illinois. Both MEK inhibitors are advancing in Phase 3 or pivotal trials: binimetinib is being evaluated in NRAS- and BRAF-mutant...

2014-05-08 23:15:38

In CHAMPS Oncology's most recent blog post, “Q” is for Quality (and QOPI Certification), Melissa Smith shares her thoughts on the topic. Cleveland, OH (PRWEB) May 08, 2014 In CHAMPS Oncology's most recent blog post, “Q” is for Quality (and QOPI Certification), Melissa Smith shares her thoughts on the topic. Smith explains that the quality of care a cancer patient receives is crucial to their survival. That’s why administrators and clinicians implement patient-centered...

2014-05-06 23:06:23

Expands Relationship of Innovation and Efficiencies (PRWEB) May 06, 2014 Florida Cancer Specialists & Research Institute (FCS), one of the largest cancer care providers in the United States, announced it will now be sourcing all of its chemotherapeutic and supportive therapy products from Oncology Supply. The agreement will go into effect immediately. "We're very pleased with the new contract and continuing our long-term partnership with Oncology Supply and International...

2014-05-06 16:32:12

Guest Speakers to Discuss Calmare® Pain Device Therapy Treatment; Company Developed Medical Milestones and Advancements to be Disclosed FAIRFIELD, Conn., May 6, 2014 /PRNewswire/ -- Competitive Technologies, Inc., (CTI), the pain mitigation company, will host a private engagement for top opinion leaders in oncology at the Hyatt Regency McCormick Place on June 1, 2014 during the 50(th) Annual American Society of Clinical Oncology (ASCO) in Chicago, IL....

2014-04-21 16:25:24

LOS ANGELES, April 21, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that the abstract describing the Company's phase II trial of dendritic cell-based cancer vaccine ICT-107 in newly diagnosed glioblastoma (GBM) has been accepted for an oral presentation at the 2014 American Society for Clinical Oncology (ASCO) annual meeting, to be held in Chicago May 30-June 3, 2014....


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related